24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

osteocalcine level (p=0,05) when girls with CC genotype .<br />

Conclusion: in our study we have revealed that GG genotype and G<br />

allele BclI GCR was associated with osteopenia in JIA girls with high<br />

osteocalcine level .<br />

P06.040<br />

S2G (Syndrome to Gene): Novel s<strong>of</strong>tware for the identification <strong>of</strong><br />

genes associated with human genetic syndromes<br />

A. Gefen, R. Cohen, O. S. Birk;<br />

National Institute for Biotechnology in the Negev, Beer-sheva, Israel.<br />

The identification <strong>of</strong> genomic loci associated with human genetic syndromes<br />

has been significantly facilitated through the generation <strong>of</strong><br />

high density SNP arrays. However, the identification <strong>of</strong> the specific disease-associated<br />

genes within such loci is still a tedious labor-intensive<br />

bottleneck. Optimal selection <strong>of</strong> candidate genes from within a defined<br />

genomic locus is a crucial step in the process .<br />

We have generated novel s<strong>of</strong>tware that selects optimal candidate<br />

genes, using a two step procedure . For any given syndrome, the s<strong>of</strong>tware<br />

seeks all genes associated with syndromes containing similar<br />

phenotypes . It then searches through the entire human genome for<br />

other genes that are associated with these reference genes . This<br />

search takes into account interacting biochemical pathways, proteinprotein<br />

interactions, transcription factor cascades, etc . A gene list is<br />

generated with an order <strong>of</strong> priority (degree <strong>of</strong> possible interaction with<br />

the reference gene(s)). This list is then filtered for the specific genomic<br />

locus in question - and a prioritized list <strong>of</strong> candidate genes is generated<br />

.<br />

S2G can be used also in clinical genetics: when S2G gets a query<br />

for related syndromes <strong>of</strong> a given one, the score vector <strong>of</strong> the given<br />

syndrome is sorted creating a list <strong>of</strong> syndromes starting with the closest<br />

related syndrome . The result <strong>of</strong> the query is a list <strong>of</strong> syndromes<br />

with their known causing genes, so one can view and explore which<br />

genes are associated with similar phenotypes to those <strong>of</strong> the query<br />

syndrome .<br />

P06.041<br />

Dystrobrevin binding protein 1 gene (DTNBP ) in a Bipolar casecontrol<br />

study (BAccs)<br />

D. Gaysina 1,2 , S. Cohen 1 , P. C. Chow 1 , L. Martucci 1 , A. Schosser 1,3 , H. A. Ball 1 ,<br />

F. Tozzi 4 , J. Perry 5 , P. Muglia 4 , I. W. Craig 1 , P. McGuffin 1 , A. Farmer 1 ;<br />

1 MRC SGDP, Institute <strong>of</strong> Psychiatry, London, United Kingdom, 2 Institute <strong>of</strong> Biochemistry<br />

and <strong>Genetics</strong>, Ufa, Russian Federation, 3 Medical University Vienna,<br />

Vienna, Austria, 4 GSK Research & Development, Verona, Italy, 5 GSK Research<br />

& Development, Greenford, United Kingdom.<br />

Background: Recent studies suggest a substantial degree <strong>of</strong> overlap in<br />

genetic susceptibility across the traditional categories <strong>of</strong> schizophrenia<br />

and bipolar disorder . There is consistent evidence for an association<br />

<strong>of</strong> the DTNBP1 gene with schizophrenia, and thus this gene has also<br />

become a focus <strong>of</strong> further investigation in bipolar disorder (BD) .<br />

Methods: The aim <strong>of</strong> our study is to explore the association <strong>of</strong> DTNBP1<br />

gene with BD and with a sub phenotype such as presence/ absence<br />

<strong>of</strong> psychotic symptoms in a sample <strong>of</strong> 465 patients with BD (ICD10/<br />

DSMIV) and 478 ethnically matched control subjects recruited from<br />

the UK . Seven SNPs <strong>of</strong> the DTNBP1: rs2743852 (SNP C), rs760761<br />

(P1320), rs1011313 (P1325), rs3213207 (P1635), rs2619539 (P1655),<br />

rs16876571 and rs17470454 were investigated using SNPlex genotyping<br />

system .<br />

Results: We report significant differences in genotypic and allelic frequencies<br />

<strong>of</strong> rs3213207 and rs760761 <strong>of</strong> DTNBP1 gene between the<br />

bipolar patients and controls . We also show a global haplotypic association<br />

and an association <strong>of</strong> a specific haplotype within this gene<br />

with BD .<br />

Conclusions: Our results are consistent with previous studies in term<br />

<strong>of</strong> a general association between the dysbindin gene and bipolar disorder<br />

and provide additional molecular genetic evidence that a portion<br />

<strong>of</strong> the genotypic overlap between schizophrenia and bipolar affective<br />

disorder is attributable to this gene .<br />

Acknowledgements: Russian Science Support Foundation Grant<br />

(Gaysina), MRC UK PhD studentship (Cohen), Erwin-Schrodinger<br />

Fellowship (Schosser), ESRC UK PhD studentship (Ball) . The casecontrol<br />

collection was supported by GlaxoSmithKline, Research and<br />

Development .<br />

P06.042<br />

A 7 mb region within 11q13 is candidate to contain a high<br />

penetrance gene for breast cancer<br />

J. M. Rosa Rosa 1 , G. Pita 1 , A. González-Neira 1 , V. Fernández 1 , R. Oldenburg 2 ,<br />

P. Devilee 3 , J. Benítez 1 ;<br />

1 <strong>Human</strong> Cancer <strong>Genetics</strong> Programme, Madrid, Spain, 2 Dept. <strong>of</strong> Clinical <strong>Genetics</strong>,<br />

Leiden, The Netherlands, 3 Dept. <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Leiden, The Netherlands.<br />

Familial breast cancer represents up to 5% <strong>of</strong> the total breast cancer<br />

cases . Only a fraction <strong>of</strong> families affected by breast cancer is explained<br />

by mutation in BRCA1 and BRCA2 . Recently, our group has<br />

performed a new SNP-based linkage study in 19 non-BRCA1/2 families<br />

from Spain, Netherlands and USA We found that a single family<br />

was linked to two different chromosomes (regions 11q13 and 14q21),<br />

and showed a non-parametric LOD score <strong>of</strong> 11 .5 in both regions . The<br />

regions spanned 28 and 14 .5 Mb respectively . We ruled out any possible<br />

translocation between both chromosomes using cytogenetic<br />

techniques . We used both a panel <strong>of</strong> STRs and an indirect approach<br />

based on HapMap data to narrow down these two regions from 28<br />

to 7Mb in chromosome 11 and from 14 .5 to 8 .5 Mb in chromosome<br />

14 . We selected the 11q13 region to perform a mutational screening<br />

on some candidate genes (NuMA1, FGF3, CCND1, RAD9A, RNF121,<br />

FADD and has-mir-192) . Although we have not found any deleterious<br />

mutation in the coding sequence <strong>of</strong> these genes, data from infrequent<br />

markers located in different genes confirms 11q13 as a candidate<br />

region to contain a breast cancer susceptibility gene . A larger study<br />

involving new families could limit their size and facilitate a more extensive<br />

mutational screening .<br />

P06.043<br />

PPP R and NFATC polymorphisms have no influence on<br />

cardiac parameters in healthy individuals and related to cardiac<br />

remodeling in patients with cardiovascular disease<br />

O. G. Ivanova 1 , O. A. Makeeva 1 , I. V. Tsimbal’uk 2 , K. V. Puzyrev 3 , O. Y. Byichkova<br />

1 , A. A. Lezhnev 3 , V. A. Kazakov 3 , V. M. Shipulin 3 , V. P. Puzyrev 1,2 ;<br />

1 Research Institute <strong>of</strong> Medical <strong>Genetics</strong>, Tomsk, Russian Federation, 2 Siberian<br />

State Medical University, Tomsk, Russian Federation, 3 Research Institute <strong>of</strong><br />

Cardiology, Tomsk, Russian Federation.<br />

Numerous data appeared supporting the notion about an important<br />

role which calcineurin pathway plays in myocardial hypertrophy, cardiac<br />

remodeling and human heart failure . Though only few studies had<br />

been reported to date which demonstrate an association <strong>of</strong> calcineurin<br />

pathway genes polymorphisms with cardiac parameters or other cardiovascular<br />

measurements .<br />

In this study we analyzed association <strong>of</strong> two calcineurin pathway<br />

genes polymorphisms (5-base pair deletion in calcineurin B promoter<br />

- 5I/5D PPP3R1 gene polymorphism and SNP rs2228309 in exon 2<br />

<strong>of</strong> NFATC4 gene - G160A) with echocardiographic parameters in 216<br />

healthy individuals . Two polymorphisms under study had previously<br />

been shown by us to be associated with left ventricular (LV) remodeling<br />

in patients with arterial hypertension .<br />

In healthy subjects we did not find association <strong>of</strong> those two polymorphisms<br />

with LV myocardium mass index, wall thickness, LV remodeling<br />

index, end diastolic size, ejection fraction or other cardiovascular<br />

parameters .<br />

To further analyze the role <strong>of</strong> two functional genetic variants we collected<br />

a group <strong>of</strong> patients with ischemic heart disease and ischemic cardiomyopathy<br />

(n=104) . We had revealed that patients differed from healthy<br />

subjects in A160G NFATC4 gene allele frequencies (p=0,046) .<br />

Our data supports the assumption that calcineurin pathway components<br />

may be involved in pathological types human heart remodeling .<br />

P06.044<br />

study <strong>of</strong> genetic risk factors for cardiovascular disease in são<br />

miguel island population (Azores)<br />

T. Pereirinha 1 , C. C. Branco 1,2 , P. R. Pacheco 1,2 , R. Cabral 1,2 , L. Mota-Vieira 1,2 ;<br />

1 Mol <strong>Genetics</strong> & Pathology Unit; Hospital <strong>of</strong> Divino Espirito Santo <strong>of</strong> Ponta<br />

Delgada, EPE, Azores, Portugal, 2 Instituto Gulbenkian de Ciencia, Oeiras,<br />

Portugal.<br />

Several genetic variants − factor V Leiden (G1691A), prothrombin<br />

(G20210A) and MTHFR (C677T and A1298C) − were found to be associated<br />

with cardiovascular disease (CVD), a frequent cause <strong>of</strong> death<br />

in many populations . The aim <strong>of</strong> this study is to investigate the preva-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!